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Being overweight or obese is one of the strongest risk factors for type 2 diabetes. 
Eswatini has a high prevalence of undiagnosed type 2 diabetes and half of its adults 
are either overweight or obese. However, there is a paucity of data on knowledge, 
attitudes and practices towards the prevention of type 2 diabetes in people at risk in 
Eswatini. This study aims to assess knowledge, attitudes and practices towards the 
prevention of type 2 diabetes mellitus among overweight and obese adults presenting 
at an urban outpatient clinic in Manzini, Eswatini. 
Methods 
A cross-sectional study of adults who were either overweight or obese attending the 
clinic was carried out. Knowledge, attitudes and practices towards the prevention of 
type 2 diabetes mellitus were assessed using a validated researcher administered 
questionnaire. Knowledge, attitudes and practices were compared between 
overweight and obese participants. In addition, the correlation between knowledge, 
attitudes and practices was evaluated using a correlation matrix. 
Results 
A total of 105 participants, with a mean age of 35.2 (SD 10.7) years participated in the 
study. Of these, 55 (52.4%) and 50 (47.6%) were overweight and obese, respectively. 
The majority of the participants showed acceptable knowledge levels, with 61% of the 
participants having good knowledge and 30% excellent knowledge. Participants 
showed positive attitudes towards diabetes prevention, 69.5% of participants had 
satisfactory attitudes, 21.0% had excellent attitudes and 9.5% had neutral attitudes 
towards the prevention of type two diabetes mellitus. Practices were generally poor 
with only 33.3% meeting the World Health Organisation recommended 150 minutes 
of physical activity per week. Just over half (53.0%) of participants who met the criteria 
for screening had screened for diabetes. Dietary practices were poor with just over a 
third (36.2%) of participants meeting the World Health Organisation recommended 
daily vegetable and/or fruit intake of five servings a day and 85.7% exceeding the 




significant differences between participants who were overweight and those who were 
obese in their knowledge, attitudes and practices towards preventing type 2 diabetes 
mellitus. There was a significant, positive correlation between total knowledge scores 
and total attitude scores (r= 0.42, p<0.01). 
Conclusion 
Overweight and obese adults visiting the outpatient clinic had satisfactory knowledge 
and attitude levels towards the prevention of type 2 diabetes. Practices towards 
prevention were generally poor with few participants meeting the World Health 
Organisation recommendations for physical activity and fruit and/or vegetable daily 
intake. Just over half of the eligible participants had screened for diabetes prior to the 
study. In addition to information, interventions are needed to motivate patients at high 
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The International Diabetes Federation (IDF) estimated that worldwide, 463 million or 
9.3% of adults aged 20-79 years were living with diabetes in the year 2019 (1). This 
figure is projected to rise to 700 million or 10.9% by the year 2045 (1). Type 2 diabetes 
mellitus (T2DM) accounts for approximately 90% of the total burden of diabetes and 
is preventible (1). Of concern is the fact that the burden of T2DM is disproportionately 
high in low-and-medium-income countries (LMIC) and is expected to increase more 
rapidly, in contrast to the better-resourced high-income countries (1). This rise in the 
prevalence of T2DM in LMIC has been attributed to ageing, increasing urbanization 
and obesogenic environments (1). Another concern is that around half of the people 
with diabetes are undiagnosed, and this proportion is higher (almost two-thirds) in 
African countries (1). Undiagnosed diabetes may lead to the more frequent occurrence 
of complications, which increases the cost of diabetes care and reduce the quality of 
life of affected people (2).  
The Kingdom of Eswatini has a population of about 1.4 million with an adult population 
(20-79yrs) of 653 300 (3). According to the World Health Organization (WHO) 
STEPwise approach to Surveillance (STEPS) study, the prevalence of diabetes 
among adults in Eswatini was 14.2% and about 60.7% of diabetic adults are 
undiagnosed (4). The Kingdom of Eswatini has a prevalence of overweight or obesity 
of 50.3%,  which is the third-highest in Africa with an overall obesity prevalence rate 
of 23.4% (5). This may imply an increase in the risk of developing diabetes in the 
future, driven by overweight and obesity. 
Risk factors for T2DM include modifiable environmental factors such as reduced 
physical activity, unhealthy dietary habits, abdominal obesity, and non-modifiable 
factors such as age and family history (2). Excess body weight is a very important risk 
factor for T2DM with excess body weight present in 87% of patients with diabetes 
mellitus in South Africa, this is according to a systematic review of studies from South 
Africa (6). In addition, overweight and obesity are major risk factors for several other 
chronic diseases which include cardiovascular disease and cancer (7). Therefore, 
people who are overweight or obese may benefit from health education interventions 




The WHO defines overweight and obesity as having an abnormal or excessive fat 
accumulation that presents a risk to one’s health (8). A crude population measure of 
obesity is the body mass index (BMI), defined as a person’s weight (in kilograms) 
divided by the square of his or her height (in meters). In African populations, a BMI of 
between 25kg/m2 and 30kg/m2 is categorized as overweight, and a BMI of 30kg/m2 or 
above is considered obese (8). The risk of developing T2DM has been shown to 
increase with an increase in BMI (9)(10). Overweight and obesity were previously 
considered a problem of developed countries, but presently also a major and 
increasing problem of LMIC countries, especially among urban populations (11). 
Increasing burdens of cardiometabolic diseases, driven by overweight and obesity in 
the LMICs, should, therefore, be anticipated. 
Research has shown that lifestyle modification interventions can help prevent or delay 
T2DM in populations that are at high risk of developing T2DM (12). Various diabetes 
prevention programs in the USA, India and China have found that participants who 
managed to lose weight by physical exercise and healthy eating reduced their risk of 
T2DM. The Diabetes Prevention Program (DPP) conducted in the USA showed a 58% 
reduction in the risk to develop T2DM in participants with impaired glucose tolerance 
(13). In India, the DPP in a community based randomized control study showed that 
lifestyle modification resulted in a relative risk reduction of 28.5% for T2DM (14). In 
China, a 20 year follow up study to assess the effect of lifestyle interventions to prevent 
T2DM found that group-based lifestyle interventions over six years can prevent or 
delay the onset of diabetes by up to 14 years (15). These studies have consistently 
shown the benefit of identifying at-risk-populations and intervening using lifestyle 
modification or pharmacotherapy in preventing or delaying T2DM. 
If people who are at risk of diabetes are to successfully change their lifestyles, then 
satisfactory levels of knowledge, attitude and practice (KAP) towards diabetes 
prevention are needed. However, data on whether good attitudes and levels of 
knowledge about diabetes prevention culminate in more prevention practices, are not 
conclusive. In India, one study showed that good knowledge and education were 
highly associated with improved care and prevention of diabetes (16). However, other 
researchers did not find any relationship between good knowledge and attitudes and 




Several studies have assessed the impact of KAP’s on the prevention of T2DM. These 
studies were conducted in general populations (17)(18), in patients with diabetes 
(7)(19) and also in select populations such as University lecturers (21). The 
assessment methodology of KAPs in different countries vary and no standardized tool 
for assessing KAPs towards the prevention of T2DM is currently available.  
Worldwide, knowledge scores on T2DM ranged from a low of 19% good knowledge in 
Bangladesh (20) to 84% in India (21). In Africa, the knowledge scores ranged from 
27% (22) in the general population in Kenya to 45% excellent knowledge among 
university lecturers in Nigeria (23). Attitude scores ranged from a low of 10% good 
attitude in Bangladesh (20) to a high of 53% good attitude in India (21). Practice scores 
also ranged from a low of 16% good practice in India (17) and a 33% good practice in 
Bangladesh (20). Interpretation and comparison of these studies are difficult due to 
the fact that the study populations differ and the absence of validated KAP assessment 
tools.  
Most of the research on KAPs towards T2DM prevention focused on the general 
population and, to our knowledge, there are no published data on the preventative 
impact of KAPs specifically in overweight and obese populations. The risk for T2DM 
increases with increasing BMI and people who are obese are at a higher risk of T2DM 
compared to those who are overweight (6). Whether people who are obese tend to 
have better KAPs towards T2DM prevention, compared to those who are overweight 
is, however, not known and have not been studied. 
Research on KAPs of at-risk people can inform prevention strategies and help develop 
targeted interventions for the at-risk groups. We found no published research on KAPs 
regarding the prevention of T2DM in the Kingdom of Eswatini. This study, therefore, 
aimed to assess the KAP's towards the prevention of T2DM in a cohort of adults 
who were overweight and obese attending an urban outpatient clinic in Manzini, 
Kingdom of Eswatini. In addition, the study explored the relationship between 
the participant’s knowledge of T2DM, attitudes towards T2DM prevention and 
their practices to prevent T2DM. The KAP's between participants who were 






Study design and setting  
This cross-sectional study was conducted at a public, outpatient, catholic, health care 
facility. It is centrally located in the urban city of Manzini which is the second-largest 
city in the Kingdom of Eswatini. The clinic serves over 100 patients per day from all 
over Eswatini. The study was carried out from the 15th of July to the 30th of August 
2019. 
Study population  
Participants aged between 18-79 years attending the public health care facility in 
Manzini were considered for inclusion in the study. For inclusion into the study, 
participants had to have a BMI of 25kg/m2 or more. Patients with known diabetes 
mellitus, pregnant women and patients too sick to be interviewed were excluded from 
the study.  
Statistical considerations 
Sample size determination 
The sample size was calculated for the primary objective of the study, which was to 
estimate the KAPs for the prevention of T2DM in participants who were overweight 
and obese. A sample size of 96 was calculated using Open Epi version 3 open source 
Calculator (24). The researchers anticipated that 15 600 eligible participants visited 
the clinic in a year. Using a design effect of one, a confidence limit of 10%, expected 
frequencies of 27% with good knowledge, 49% with a good attitude and 41% with 
good practice from a KAP study in Kenya among the general public (22), calculations 
yielded a sample size of 96. The sample size was increased by 10% to allow for 
incomplete responses.  
Sampling technique 
Participants were selected through a systematic sampling technique, selecting every 
fifth patient. This sampling interval was informed by the daily patient numbers and 
the proportion estimated to be overweight and obese, to allow for the recruitment of 
the full sample size of 100 within six weeks. Routine vital signs including height and 




The BMI was calculated from these routine measurements to determine eligibility for 
study participation. If the selected participant did not meet the inclusion criteria, the 




Data collection  
Anthropometry 
Anthropometric measurements, weight (in kilograms) and height (in meters), were 
repeated on participants included in the study by the researcher and BMI was again 
calculated. A scale and stadiometer calibrated daily were used to measure weight (to 
nearest whole number) and height (to two decimal places) respectively. Patients were 
all requested to remove footwear and any headgear for the measurements.  
Questionnaire 
A structured, interviewer-administered questionnaire was used to collect data 
(Appendix 2). The questionnaire was administered by the researcher and research 
assistant in either English or siSwati depending on the language the participant 
preferred. The English questionnaire was translated by a professional translator to 
siSwati through a rigorous process that ensured the same meaning was maintained. 
Back translations were done to ensure validity. Questions on KAPs were adapted and 
modified by the researcher after reviewing different literature and other questionnaires 
(7)(21)(25). The questionnaire was revised after a pilot study to determine the 
relevance and comprehensiveness of the questions was conducted with 10 
participants, and through consultation with clinical staff. The results of the pilot and 
amendments made to the questionnaire are described in Annexure.  
 
The siSwati questionnaire was found to be difficult for participants who chose to 
answer in siSwati, participants preferred to have a mix of English and siSwati during 
the interview. Participants commonly used the term “sugar disease” to mean diabetes, 
so in some instances, interviewers adapted this term to clarify diabetes mellitus when 
participants did not understand. The pilot study also helped to refine data entry and 
coding of items.  
Questionnaires were administered in a private room while patients were waiting for 
medications at the pharmacy after completing their consultation. Study participants 
were asked to complete the interview which took an average of 20 minutes. After 
participation, patients were assisted in obtaining their medication to avoid further 




Assessment of Socio-economic status (SES) 
We developed a scale on the basis of 12 item ownership in the household of the 
participant to reflect the standard of living. The assessment scale was adopted and 
modified from a previous validated wealth index scale, developed for rapid 
socioeconomic assessment for use by health care workers using item ownership as 
a measure of wealth(26). Assets included essential items such as electricity and 
running water, useful items such as television and radio and non-essential items 
included a washing machine, motor vehicle and swimming pool.  
If the individual had access to 50% or more of the assets in their household, they were 
ranked middle SES. Having 50% or more items meant they possessed one or more 
of the useful and non-essential items in the list. If respondents had less than 50%, 
they were ranked low middle SES and they possessed mostly essential assets and 
just about 1 useful item. 
Assessment of KAPs 
Determination of knowledge of T2DM and its prevention 
This section had 40 yes/no questions to assess knowledge on disease prevalence, 
the effect on the body, predisposing factors, signs and symptoms, and prevention. A 
correct response was scored 1 and incorrect scored 0. An overall knowledge score 
for a participant was calculated by adding scores for each question. The highest 
possible score was 40. The score was converted to a percentage. Participants who 
managed to answer at least half of the questions, 50%, were considered to have 
sufficient knowledge with regards to the prevention of T2DM and were classified as 
having good knowledge in this study. Those who scored 75% and above were 
regarded as having excellent knowledge towards the prevention of T2DM, however 
those who scored less than 50% were considered to have poor knowledge. 
Determination of attitudes towards the prevention of T2DM 
The section had 10 questions with a five-point Likert scale and the most appropriate 
response was given a score of 5 and the least appropriate was given a score of 1. 
Participants either agreed or strongly agreed to positive statements or disagreed or 
strongly disagreed with negative statements with a total possible score of 50. 




“negative” if score was between 11-20, “neutral”, for 21-30, “satisfactory” for 31-40, 
and “excellent” for 41-50. 
Determination of practices related to the prevention of T2DM 
The practice section was assessed in three domains. 
Domain 1: Physical activity 
The physical activity of each participant was calculated based on the WHO 
global physical activity questionnaire (GPAQ) (27). The total number of minutes 
of moderately intense and vigorous exercise performed on a weekly basis by 
each participant was documented and included all work-related and leisure 
activities. Travel related physical activity was also included in calculating the total 
number of minutes of physical activity per week. Total physical activity was 
calculated by adding vigorous and moderate-intensity work-related activity, 
travel-related physical activity (walking included) as well as both vigorous and 
moderate leisure activities. The optimal recommended 150 minutes of weekly 
physical activity required to improve cardiovascular and metabolic health was 
used to define the practice of physical activity in participants as either good for 
those who met the WHO recommendations (>150 minutes/week) or poor for 
those who did not meet the WHO recommendations (< 150 minutes/week) (28). 
Domain 2: Dietary practice  
The second domain measured dietary practices. Daily fruit and vegetable servings 
were recorded as reported by participants. A serving was considered as a whole fruit 
or half a 250ml cup of fruits or vegetables. Consuming five or more servings of fruit 
and/or vegetables per day was considered a good dietary practice and consuming less 
than five servings was regarded as poor dietary practice (29). This domain also 
assessed daily sugar intake. Participants were asked how much sugar (in teaspoons) 
they added to their meals, in coffee, tea or other beverages. Added sugar was 
also determined from the amount of fizzy drink (330 ml, one glass/can), fruit juice, 
sugar-containing diluted drinks, and alcoholic beverages. The total daily sugar 
consumption in teaspoons was calculated for each participant. Poor dietary practice 
was recorded if the participant exceeded six teaspoons of added sugar per day and 
good if they consumed six or fewer teaspoons of added sugar per day as per WHO 




Domain 3: Screening for T2DM 
The T2DM screening practices of participants were assessed in this domain. 
Participants were asked if they had ever screened for T2DM by finger prick test for 
blood glucose. Screening for T2DM is recommended for high-risk individuals with a 
BMI of 25kg/m2 or more with another additional risk. The Society for Endocrinology, 
Metabolism, and Diabetes of South Africa (SEMDSA) guidelines for the management 
of T2DM recommend targeted screening every three years in high-risk individuals who 
are overweight and have an additional risk factor (31). Additional risk factors 
considered in this study were: 
• not meeting the WHO recommendation of 150 minutes of physical activity per 
week. 
• hypertension 
• first-degree relative with diabetes 
• history of gestational diabetes 
• high-risk race in this study being Asian 
• age of 45 or more 
The total number of participants with one or more of these additional risk factors was 
determined and screening practices were determined in these individuals. Screening 
practice was poor if the eligible participant had not screened and good if they had 
previously screened for diabetes. 
Determination of the relationship between KAPs 
The relationships between each of KAPs regarding the prevention of T2DM was 
assessed. Three relationships were assessed; knowledge-attitude, attitude-







Figure 1 The Knowledge-Attitude-Practice Model (Schwartz, 1976) 
 
The K-A-P model which is based on the cognitive-affective-behaviour theory in social 
psychology (32) suggests that an increase in knowledge affects attitude and 
consequently practices. The model is based on the notion that increasing personal 
knowledge will influence behavioural change (32). It is therefore hypothesized that 
participant’s knowledge about T2DM prevention may influence the way they will 
develop certain attitudes and practices regarding the prevention of T2DM. 
Data extraction and statistical analysis 
Data was captured into Microsoft Office Excel using double entry. Data were cleaned 
and checked for missing entries and stored in a password-protected computer. 
Stata version 14 (33) was used to analyse data. Frequencies and percentages were 
used to describe categorical data, while means and standard deviations (SD) were 
used to describe normally distributed numerical data. If the numerical data were not 
normally distributed, medians and interquartile range (IQR) were used to describe the 
data. For comparing categorical data, chi-square tests or Fisher’s exact tests (where 
chi-square was not valid) were used to test for association. The Wilcoxon rank-sum 
test was used to compare numerical data between overweight and obese groups. A 
correlation matrix was also used to assess the relationship between KAP scores. We 
compared the KAP's between participants who were overweight and those who 
were obese. A p-value of 0.05 was considered statistically significant. 
Ethical considerations  
All participants signed informed consent before proceeding with interviews (Appendix 




Committee (HREC) of Stellenbosch University (reference # S18/08/160) (Appendix 5) 
and the Eswatini National Health Research Review Board (reference # 
SHR129/2019) (Appendix 6). The clinic management also approved the study 
(Appendix 7). The principles of Helsinki and Good Clinical Practice were adhered to 
(34). 
Results 
Socio-demographic characteristics of participants 
Table 1 shows the socio-demographic characteristics of the participants. A total of 
105 patients participated in the study and the majority (61.9%) were female. The mean 
age was 35.2 years (SD 10.7). Most participants (84.8%) were below the age of 45 
years. Just over half (52.4%) were overweight and the remainder were obese. Almost 
a quarter (23.8%) of the participants were known hypertensive patients while 42.9% 
of the participants had a close family history of diabetes. The majority (85.7%) of 














































































*Notes: DM diabetes mellitus, SES- socioeconomic status 
Variable  Total 
N=105 
 
 Category n % 
Gender Male 40 38.1 
 Female 65 61.9 
Age 18-44  89 71.4 
 45 and above 16 15.2 
BMI class Overweight 55 52.4 
 Obese 50 47.6 
Race Black 97 92.3 
 Coloured 2 1.9 
 White 1 1.0 
 Asian  5 4.8 
Marital Status Single 51 48.6 




Religion Christianity 97 92.4 
 Islam 6 5.7 
 None 2 1.9 
Education Primary or less 8 7.6 
 Secondary 9 8.6 
 High school 44 41.9 
 Tertiary 44 41.9 
Residence Urban 65 61.9 
 Rural 40 38.1 
Income Employed 77 73.3 
 Unemployed 20 19.1 
 Student 8 7.6 
SES Low 28 26.7 
 Medium 77 73.3 
Has hypertension,   Yes 25 23.8 





History of gestational 
diabetes in females,   
Yes 4 6.2 





Previously had  
education on DM 




Knowledge of T2DM and its prevention 
The most common sources of information on diabetes reported by participants were 
health care workers (62.2%) and friends and family (54.4%) (Figure 2). Table 2 shows 
the participant’s knowledge levels. Most 92(87.6%) of the participants reported 
knowing that diabetes was a common disease. The feet, 93(88.6%) and the eyes 
89(84.8%) are the body parts most people knew were affected by diabetes. Less than 
half, 31(29.5%), of the participants, knew the lungs could be affected by diabetes and 
only 44(41.9%) knew the mouth was affected by diabetes. 
Being overweight or obese was identified by 97(92.4%) as a predisposing factor for 
T2DM, lack of physical activity or not exercising was rightly identified by 102(97.1%) 
of the participants as a possible risk factor for developing T2DM. Only 43(41.0%) 
correctly identified mental stress as a possible risk factor for developing diabetes. A 
fair number of participants 68(64.8%) knew that T2DM could be prevented. 
Figure 3 presents the participants’ responses on the ways of preventing T2DM. 
The median overall knowledge score on the prevention of T2DM was 27(IQR 25-31). 
When scores were classified, most (61.0%) of the participants had good knowledge, 
30.5% had excellent knowledge, and only 8.6% had poor knowledge with regards to 
the prevention of T2DM. 
There was no difference in knowledge scores between overweight and obese 






















Table 2 - Participants’ knowledge about the effects, predisposing factors and 
the prevention of diabetes. 
*Responses were yes or no answers 
Knowledge domain/question Correct responses 
by participants 
          N=105 
 n % 
1. Diabetes is common these days 92 87.6 
2. Parts of body affected by diabetes   
a. Eyes 89 84.8 
b. Heart 69 65.7 
c. Lungs 31 29.5 
d. Stomach 40 38.1 
e. Kidneys 85 80.9 
f. Feet 93 88.6 
g. Brain 71 67.6 
h. Hands 66 62.9 
i. Nerves 77 73.3 
j. Skin 75 71.4 
k. Mouth (gums and teeth) 44 41.9 
3. Predisposing factors   
a. Having a family member who has/had diabetes 84 80.0 
b. Having high blood pressure 79 75.2 
c. Being overweight/obese 97 92.4 
d. Consuming more sugar sweetened beverages such as coca 
cola and sweetened foods. 
73 69.5 
e. Staying in the same room with someone who has diabetes 103 98.1 
f. Not being physically active or not exercising 102 97.1 
g. Being bewitched/evil spirits 98 93.3 
h. Having mental stress 43 41.0 
4. Type 2 Diabetes can be prevented. 68 64.8 




                
 
Figure 2 Participants’ sources of information about diabetes. *HCP- a health care 
professional, HCW-health care worker, IEC-information, education and communication materials. 
Participants were asked to select a source of information on diabetes education. 
 
 
                
  
Figure 3 – Participants’ knowledge about ways of preventing diabetes. 
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Attitudes towards prevention of T2DM 
Table 3 shows the attitudes of participants towards diabetes prevention. Most 
participants (80%), either agreed or strongly agreed that their personal effort would 
help to control their risks of developing T2DM. Just over half of the participants, 
(55.2%) disagreed or strongly disagreed that they were less likely to get T2DM 
compared to people of the same age with normal weight. Although 55.2% felt that 
regular exercise and weight loss programs took a lot of effort, most participants 
(74.3%) believed that the benefits of weight loss and exercise outweighed the effort 
needed to do it. 
The median attitude score was 37 (IQR 34-40), with a minimum score of 26 and a 
maximum of 49. The majority (69.5%) of participants had satisfactory attitudes, 21.0% 
had excellent attitudes and 9.5% had neutral attitudes towards the prevention of T2DM 
No differences in attitudes towards prevention of T2DM were observed between 




Table 3 - Participants’ beliefs and attitudes about the prevention of diabetes.  
 
 
Practices related to the prevention of T2DM 
Table 4 shows the participants practices towards diabetes prevention. Most minutes 
of physical activity were attained through moderate physical activity either at work or 
during leisure and walking time which had a median of 30 minutes each. Vigorous 
work and leisure activities both had zero median minutes. Participants with less than 
50 minutes of physical activity per week were 24.8%, participants with 50 to 100 
















I have little control over risks to 
my own  
4(3.8) 27(25.7) 12(11.4) 38(36.2) 24(22.9) 
If I am going to get diabetes, 
there is nothing much I can do 
about it 
1(1.0) 15(14.3) 16(15.2) 50(47.6) 23(21.9) 
Personal efforts will help 
control my risk of getting 
diabetes 
30(28.6) 54(51.4) 15(14.3) 6(5.7) 0(0.0) 
People who make efforts to 
control risks of diabetes are 
less likely to diabetes mellitus 
20(19.1) 60(57.1) 13(12.4) 9(8.6) 3(2.8) 
I am less likely to get diabetes 
compared to other people of 
same age 
6(5.7) 15(14.3) 26(24.8) 51(48.5) 7(6.7) 
I am less likely to get a serious 
disease compared to other people 
of same age 
2(1.9) 18(17.1) 24(22.9) 48(45.7) 13(12.4) 
Doing regular exercise and 
following a weight loss diet take a 
lot of effort 
21(20.0) 37(35.2) 8(7.6) 31(29.5) 8(7.6) 
The benefits of following a weight 
loss diet and exercise program 
outweigh the effort to do it 
13(12.4) 65(61.9) 23(21.9) 4(3.8) 0(0.0) 
Regular exercise and diet may 
prevent diabetes from developing 
26(24.8) 62(59.0) 13(12.4) 4(3.8) 0(0.0) 
Diabetes mellitus can be 
prevented 




minutes per week were 26.7%, those with above 100 but less than 150 were 15.2%  
and 33.3% had the ideal minutes, 150 or more, of physical activity per week as 
recommended by WHO. 
Just over a third (36.2%) of participants had good dietary practices related to fruit and 
vegetable intake and only 14.3% of participants had good practices towards sugar 
intake. 
Fifty of the 105 participants (47.6%) reported that they had ever screened for 
diabetes. Of the 83(79.0%) participants with one or more of the six additional risk 
factors assessed in this study, only 44(53.0%) had ever screened for T2DM. Of the 






















































*Notes 1. Total *carbohydrate meals represent the frequency of all bread, pap, rice meals.Total sugar 
from added sugar, fizzy drinks, juice with added sugars and beverages with added sugar. 2. A can of 
fizzy drink was assumed to contain 10 teaspoons of sugar, 500mls diluted juice (oros) with added 
sugar assumed to have 2 teaspoons of sugar. 3. Abbreviations PA- physical activity, IQR- interquartile 
range 
 
PRACTICE DOMAIN  
1. Physical activity(minutes per week) Median (IQR) 
Vigorous physical activity per week 0(0-60) 
Moderate physical activity per week 40(0-90) 
Walking time per week 30(15-45) 
Sitting time per week 300(180-360) 
Total physical activity  90(50-210) 
PA minutes per week < 50 26(24.8) 
50 to 100 PA minutes per week 28(26.7) 
100 < PA minutes per week < 150 16(15.2) 
PA minutes per week >= 150 35(33.3) 
2. Diet (daily intake) Median (IQR) 
Fruits (whole fruit) 2(2-3) 
Vegetables (1/2 cup) 2(1-2) 
Water (litres) 1.5(1-2) 
Fizzy drinks (can) 1(1-1) 
Juice with added sugar(500mls) 1(0-1) 
Added sugar in tea/coffee (teaspoon) 2(2-3) 
Diet (Daily total intake)  
Total fruit and vegetable servings 4(3-5) 
Total carbohydrate meals/day 15(13-33) 
Total teaspoons sugar/day 14(12-16) 
Diet (WHO daily dietary  recommendations) n(%) 
Recommended daily fruit& veg intake (5 or more servings) 38(36.2) 
Recommended daily sugar intake   (less than 6 teaspoons) 15(14.3) 
3. Screening n(%) 
Total screened for diabetes (yes) 50(47.6) 
< 45 years  39(43.8) 
 45 years  11(68.8) 
Meet criteria for screening 83(79.0) 
Screened when eligible 44(53.0) 




Comparison of KAPs between overweight and obese participants 
Table 5 shows a comparison between overweight and obese participant’s knowledge, 
attitudes and practices towards diabetes prevention. There was a tendency for 
overweight participants to have higher knowledge and attitude scores, and to be more 
physically active although the difference did not reach statistical significance. There 
were no differences in either diet or screening practices between overweight and 
obese participants. 
 
Table 5 - Comparison of knowledge, attitude and practices between overweight 
and obese participants 
 






Knowledge score  27(23-30) 26.5(23-32) 0.76 
Attitude score  37(34-41) 37(34-39) 0.50 
Practice scores 
   
Domain 1: Physical activity(min/wk)   
        
   
Vigorous  0(0-60) 0(0-60) 0.53 
Moderate  60(0-90) 30(0-90) 0.36 
Walking time  50(20-45) 30(0-30) 0.08 
Total  90(70-240) 90(30-180) 0.26 
Domain 2: Dietary     
Total fruit/veg servings per day 4(3-5) 4(3-5) 0.71 
Total sugar teaspoons per day 13(12-16) 14(12-15) 0.94 
Domain 3: Screening domain     
Participants screened n(%) 26(52.0) 24(48.0) 0.55 





Correlation between KAPs 
There was a moderate positive correlation between knowledge scores and attitude 
scores (r=0.42, p<0.01). Knowledge scores and the dietary practice of daily fruit and 
vegetable intake showed a weak positive correlation (r=0.25, p=0.01). Attitude score 
and the dietary practice of daily fruit and vegetable intake also showed a weak positive 
correlation (r=0.20, p=0.04)). There were no other significant correlations between 
other KAPs (Table 6). 
 
Table 6 - Correlation matrix of KAPs 
*Spearman correlation   














Attitude score      
Correlation      
coefficient  
1.00     
observations 105     
significance      
Knowledge 
score 
     
Correlation      
coefficient 
0.42 1.00    
observations  105 105    
significance <0.01     
Physical activity 
minutes/week 
     
Correlation      
coefficient 
0.15 0.03 1.00   
observations 105 105 105   
significance  0.14 0.80    
Total fruit and 
vegetable 
servings/day 
     
Correlation      
coefficient 
0.20 0.25 -0.17 1.00  
observations 105 105 105 105  
significance  0.04 0.01 0.09   
Total teaspoons 
of sugar/day 
     
Correlation      
coefficient 
-0.03 -0.13 -0.14 0.00 1.00 
observations  105 105 105 105 105 





We found satisfactory levels of knowledge and attitudes in overweight and obese 
patients visiting the outpatient clinic. The vast majority (91.0%) of the participants had 
either good or excellent knowledge and satisfactory or excellent attitudes (90.5%). All 
the domains of practices towards the prevention of T2DM were however suboptimal. 
Only 33.3% met the recommended WHO 150 minutes of physical activity per week. 
The mean duration of exercise in the cohort was 90 minutes per week (IQR: 50-210). 
Just over a third (36.2%) of participants adhered to the WHO recommendation of at 
least five servings of fruit or vegetables per day and a mere 14% of the participants 
met the WHO recommendation to limit added sugar in food to six or fewer teaspoons 
daily. Less than half (47.6%) of all the participants screened for diabetes, and just over 
half 44(53%) of participants fitting criteria for screening had screened for diabetes. In 
those 45 years and older, 68.8% had a prior screening for diabetes. A moderate 
positive linear relationship was noted between knowledge and attitudes towards the 
prevention of diabetes.  
The high knowledge scores in our study are consistent with findings from other KAP 
studies among non-diabetic populations in other developing countries; India, Nigeria 
and Sri Lanka (21)(35)(25). The high knowledge scores observed in this study may be 
due to the fact that the majority (85.7%) of participants had received some form of 
health education on diabetes previously. When sources of health information were 
explored, health care workers and family and friends were the most popular sources 
of information. The good knowledge scores may also be attributed to the advanced 
and developed social and media networks where information can easily be accessed 
and passed around on smartphones (36). These high knowledge scores suggest that 
current interventions in Eswatini such as providing health education appear to improve 
knowledge and attitudes towards the prevention of T2DM 
Most participants attained satisfactory or excellent attitude scores towards the 
prevention of T2DM. However, only about half of participants (55%) felt they were at 
an increased risk of developing T2DM compared to similarly aged people of normal 
weight. There is a scarcity of data on the prevalence of T2DM in people who are 
overweight or obese from the Sub-Saharan African region. Data from a systematic 




of people with T2DM and stated that obesity should be regarded as a significant 
contributor to the high prevalence of T2DM. 
Our findings of a low-risk perception amongst participants are similar to data from the 
Netherlands (37), where almost half of the high-risk group members were not aware 
of their risk for diabetes (3). A meta-analysis study on the relationship of risk 
perception and health behaviour showed that risk perception is linked to health 
behaviour change(39) and that people are motivated to adjust health behaviour when 
they realize they are at risk. The low risk perception in our study may be one of the 
reasons why the practices towards T2DM prevention were poor. Interventions aimed 
at increasing T2DM risk perception among people who are overweight or obese may 
help in improving practices, although research evidence is needed. 
According to the health belief model, high knowledge translates to positive attitudes. 
In this study, the positive correlation between knowledge and attitude is supported by 
the theory from the K-A-P model which is based on the cognitive-affective-behaviour 
theory in social psychology. This model also suggests that an increase in knowledge 
affects attitude and consequently practices. The model is based on the notion that 
increasing personal knowledge will influence behavioural change (32).  
We found that the high levels of knowledge and attitudes did not translate to good 
practices, contrary to the K-A-P model assumption (32). Practices related to diabetes 
prevention were poor and in keeping with other studies (7)(17). Less than half of the 
participants had good practices in all three domains assessed. Only 33.3% met the 
recommended WHO 150 minutes of physical activity per week. This proportion is 
much less than that reported in the WHO STEPS study carried out in Eswatini in 2015 
where 84.7% of respondents met the WHO recommendations of physical activity (4). 
A key difference between our study and the WHO STEPS study is that the latter 
assessed practice in the general population compared to our high-risk group. Our 
findings could be partly explained by research findings indicating that overweight and 
obese individuals have lower physical activity, compared to those of normal weight 
(40). The link between attitudes and practices is seen in that more than half of the 
participants believed that exercise and a weight loss diet takes a lot of effort. This 
shows that extra motivation will be needed to improve practices in this domain. On the 




to happen without effort will not be easily discouraged. Research on interventions that 
help improve both diet and physical activity in those who are overweight or obese in 
our setting or similar settings, is needed since research is scarce in this area. 
Practices related to diet were particularly poor overall. Just over a third (36.2%) of 
participants adhered to the WHO recommendation of at least five servings of fruit or 
vegetables per day. This is more compared to the 2015 WHO Steps study carried out 
in Eswatini which reported only 7.9%(CI:6.4-9.5) (4). The majority, 86% of the 
participants did not meet the WHO recommendation to limit added sugar intake to six 
or fewer teaspoons daily, their addeded sugar intake was more than the daily 
recommendation. This may be related to the participants consuming the “hidden” 
sugar in sugar-sweetened beverages. To our knowledge, there is no research on 
consumer’s knowledge of the components of the foods they consume and on whether 
food labelling has improved this, in Eswatini. It is possible that the participants 
consumed sugar while being unaware of how much they consumed.  
Just over half of the participants with an additional risk factor reported that they had 
screened for diabetes. When participants feel they are not at risk of diabetes, they are 
less likely to screen for the disease. A study in South West Nigeria recorded a very 
low screening practice among university staff, it observed that only 66(23.6%) out of 
300 participants had ever screened for diabetes (35). We found that the majority of 
the participants who were over the age of 45 years had previously screened for T2DM, 
but a small proportion of participants of our cohort fell into this age category. It was 
pleasing to note that older adults attending a health facility are being screened, 
suggesting that the facilities are being vigilant in screening older clients though there 
is room to improve.  
Several studies have shown that the risk of developing T2DM increases with the 
degree of excess body weight (6)(10). BMI was found to be a predictor of weight 
control advice and counselling on lifestyle adjustment in primary health care settings 
by health care providers (41). Obese participants, as the higher risk category 
compared to those who are overweight are thus expected to have received health 
education at clinic visits which should result in higher knowledge levels, attitudes and 
subsequently better practices. Our study did not find any statistical difference in 




The small sample size of this study limits the conclusions that can be drawn from the 
findings. More rigorously designed studies with larger sample sizes are recommended 
to build upon findings from this study. Due to a paucity of similar research in this field, 
tools and assessment criteria have not been validated in other research. As the 
questionnaires used to evaluate knowledge and assess attitude have not been 
validated, they can be improved upon and should be tested in larger patient 
populations. We, however, conducted a pilot study to assess instrument reliability and 
internal validity. Another limitation of this study is that physical activity and dietary 
information were self-reported. Diet is a particularly difficult concept to assess, even 
with a validated food frequency questionnaire. We did not assess carbohydrate, 
protein and fat intake in calories/ kilojoules which would have given a more 
comprehensive assessment of total food intake. Physical activity is better assessed 
with accelerometers, which tend to be expensive. Qualitative research may help to 
explain why good knowledge and attitudes did not translate into better practices. 
Research on the proportion of people who are overweight or obese that develop T2DM 
is needed as well as context-specific diabetes prevention programs relevant to our 
setting. 
Conclusion 
We found acceptable levels of knowledge and attitudes, but generally poor practices 
towards the prevention of T2DM among overweight and obese adults attending an 
outpatient clinic in Manzini, Eswatini. More research is needed to explore why the 
good levels of knowledge and attitudes observed did not translate to good practices 
towards the prevention of T2DM so as to improve practices related to the prevention 
of T2DM in high-risk groups. Additional interventions aimed at increasing T2DM risk 
perception among people who are overweight or obese may also `help in improving 
practices, as well as interventions to improve motivation to initiate and sustain new 
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Chapter 2- Appendices 
Appendix 1. Review of research on KAP  
 
Table 7: Research Studies on KAP on Prevention of T2DM in Developing Countries 
Title of Study Author, 
year 
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Questionnaire on Knowledge, attitudes and practices with regards to prevention of type 
2 Diabetes Mellitus (T2DM) among overweight and obese adults. 
 
Part A: Socio- Demographic data 
Read: I would like to ask you questions related to your personal, social and medical 
history. 
SECTION 1: GENERAL INFORMATION 
Participant study number: ……………………………………………… 
  Participant suburb of 
residence………………………………………………………………… 
 
Consent has been read and obtained?               Yes, if yes continue 
 
                                                                             No, if no, STOP 
  Date of interview: 
 D D M M Y Y Y Y  
  
Age of participant at last birthday…………… 
 
 
Participant gender:    Male ……1    Female…..2     Other ......3   
 
 
Height-------------(m)  Weight-------------(kg)  Waist circumference-----------
(cm)  










SECTION 2:  SOCIO-DEMOGRAPHIC INFORMATION 
  





What is the highest level of 
education that you have achieved? 
  
  No school 1 
  Primary school 2 
  Secondary school 3 
  High school  4 
  Tertiary education 5 
    
2B What do you do for work or 
income? 
Employed, salaried 1 
  Self-employed 2 
  Unemployed 3 
  A full-time homemaker 4 
  A pensioner 5 
  On a grant 6 
  A student  7 
    
2C What is your religion? Christianity 1 
  Islam 2 
  Hindu 3 
  Baha’i 4 
  Traditional 5 
  None 6 
  Other 7 
    
2D What ethnicity do you identify 
yourself as? 
Black 1 
  Coloured 2 
  White 3 
  Asian 4 
  Other  5 
    
2E Are you……. Single 1 
  Married(civil/traditional
)/ live in partner 
2 









  Divorced/Separated 4 
    
2F Does your household have: 
 
YES NO 
            Electricity? 1 0 
            A radio? 1 0 
            A television? 1 0 
            A landline? 1 0 
            A cellphone 1 0 
            A refrigerator? 1 0 
            A microwave? 1 0 
  A personal computer (PC)? 1 0 
  A washing machine? 1 0 
            Access to tap water?  1 0 
            A motor car? 1 0 
            Swimming pool? 1 0 
    
 




Has a doctor or nurse or health worker at a clinic or hospital told you 
that you have or have had any of the following conditions: 
 
3A 






Diabetes during pregnancy (this 
usually goes away after the 
pregnancy) 

















High blood cholesterol or fats in 
the blood? 
 








SECTION 4: FAMILY MEDICAL HISTORY 
 Now I would like to ask you about your family.  Do you have a close 
blood relative (father, mother, brother, sister or child) who has ever 






Pressure?   








(this usually goes 
away after the 
pregnancy) 






YES…1 NO…0 DON’T 
KNOW…9 
 
SECTION 5: INFORMATION ON DIABETES 
5A Have you ever been told about diabetes? YES…1 NO…0 
    
5B If yes, who told you?(tick all applicable) Media (tv, radio, 
social media, phone) 
1 
  Medical personnel 
(nurse, doctor or any 
medical practitioner) 
2 
  Friends / family 3 
  Health promotion 
material (pamphlets, 
charts, bill boards) 
4 















Part B: Knowledge, Attitude and Practice Questions 
 
I would like to ask you questions with regards to knowledge of diabetes mellitus. 
These questions refer to the way you understand the disease.  
SECTION 6: KNOWLEDGE OF TYPE 2 DIABETES AND ITS PREVENTION 
 
QUESTIONS AND FILTERS 
 
Response and  Score 
6A Have you ever heard of a condition 
called diabetes mellitus? 
YES …1 NO… 0 
6B Do you think in general; more people 
are being affected with diabetes 
these days? 
YES … 1 NO….0 DON’T 
KNOW…0 
6C Which of the following parts of the 
body you think may be affected 
diabetes mellitus? 
YES NO 
            Eyes 1 0 
  Heart 1 0 
  Lungs 1 0 
  Stomach 1 0 
  Kidneys 1 0 
  Feet 1 0 
  Brain 1 0 
            Hands 1 0 
            Nerves 1 0 
            Skin 1 0 
            Mouth- gums and teeth 1 0 
    
6D            Which of the following would 
you consider to make 
someone develop diabetes 
mellitus more easily compared 
to others? 
YES NO 
 Having a family member who has or 
had diabetes  
1 0 
 Having high blood pressure 1 0 
 Being overweight/ obese 1 0 
 Consuming more sugar sweetened 







QUESTIONS AND FILTERS 
 
Response and  Score 
 Staying I the same room with 
someone who has diabetes 
0 1 
 Not being physically active or not 
exercising 
1 0 
 Being bewitched/ evil spirits 0 1 
 Having mental stress 1 0 
    
6E Which of the following are signs or 
symptoms of diabetes? 
YES NO 
 Increased urination 1 0 
 Increased thirst 1 0 
 Jaundice 1 0 
 Weight loss 1 0 
 Diarrhea 1 0 
 High blood sugar level 1 0 
 Weight gain 1 0 
 Increased hunger 1 0 
 Weakness 1 0 
    
6F Can diabetes be prevented? 
 
YES…1 NO…0 DON’T 
KNOW…0 
6G If yes, in which of the following ways 
do you think it can be 
prevented?            
Yes No 
            Reducing food portion size 1 0 
            Fruits and vegetables 1 0 
            Reducing food and drinks with 
sugar 
1 0 
            Increased physical activity 1 0 





QUESTIONS AND FILTERS 
 
Response and  Score 
            Hospital medication 1 0 
            Regular screening for 
diabetes 
1 0 
            Maintaining weight 1   0 
            Traditional medicine 0 1 
             Yes No 






















I would like to ask you questions about your attitude towards prevention of T2DM. By 
attitude I am referring to the way you feel towards the questions I will ask. 
























7A  I feel that I have little control over 
risks to my health 
1 2 3 4 5 
7B If I am going to get diabetes 
mellitus, there is not much I can do 
about it 
1 2 3 4 5 
7C I think that my personal efforts will 
help control my risks of getting 
diabetes 
5 4 3 2 1 
7D People who make a good effort to 
control the risks of getting diabetes 
mellitus are much less likely to get 
diabetes mellitus 
5 4 3 2 1 
7E Compared to other people of my 
same age, I am less likely than they 
are to get diabetes mellitus 
1 2 3 4 5 
7F Compared to other people of my 
same age, I am less likely than they 
are to get a serious disease 
1 2 3 4 5 
7G Doing regular exercise and following 
a weight loss diet take a lot of effort 
1 2 3 4 5 
7H Benefits of following a weight loss 
diet and exercise program outweigh 
the effort to do it. 
5 4 3 2 1 
7I Regular exercise and diet may 
prevent diabetes mellitus from 
developing 
5 4 3 2 1 
7J Diabetes mellitus can be prevented. 
 




SECTION 8: PRACTICES RELATED TO T2DM PREVENTION 
 
8.1 PHYSICAL ACTIVITY- MODIFIED STEPS/GPAQ  
 
The next questions are about the time you spend doing different types of 
physical activities.  This includes activities you do at home, at work, 
travelling from place to place and during your spare time.  You are 




Occupation-Related Physical Activity (paid or unpaid work):  When 
answering the following questions, think back over the past 12 months and 
consider (think of) a usual week. 
 
8.1A 
Does your work involve vigorous activities that cause large increases in 
breathing or heart rate (like heavy lifting, digging, or heavy construction) 





 If No, go to question 9D 
 
8.1B 
In a usual week, how many days do you do vigorous activities as part of your 
work? 
 DAYS:   
 
8.1C 
On a usual day on which you do vigorous activities, how much time do you 
spend doing such work? 
 1 HOURS:   
 2 MINUTES:    
 
8.1D 
Does your work involve moderate-intensity activities, that causes small 
increases in breathing or heart rate (like brisk walking or carrying light loads) 











In a usual week, how many days do you do moderate-intensity activities as 
part of your work? 
 Days:   
8.1F 
On a usual day on which you do moderate-intensity activities, how much time 
do you spend doing such work? 
 1 Hours:   
 2 Minutes:    
 
Travel-related physical activity: other than activities that you’ve already 
mentioned, I would like to ask you about the way you travel to and from places 
(to work, to shopping, to market, to church, to visit friends and relatives etc.). 
8.1G 
Do you walk or use a bicycle (pedal cycle) for at least 10 minutes at a time to 
get to and from places? 





 If no, go to question 8.1J 
8.1H 
In a usual week, how many days do you walk or cycle for at least 10 minutes 
to get to and from places? 
 Days:   
8.1I On a usual day, how much time do you spend walking or cycling for travel? 
 1 Hours:   
 2 Minutes:    
 
Non-work related and leisure time physical activity:  the next questions 
ask about activities you do in your leisure or spare time, for recreation or 
fitness.  Do not include the physical activities you do at work or for travel 
already mentioned. 
8.1J 
In your leisure or spare time, do you do any vigorous activities that cause large 
increases in breathing or heart rate (like running or strenuous  
 






 If no, go to question 8.1M 
8.1K 
In a usual week, how many days do you do vigorous activities as part of your 
leisure or spare time? 




8.1L How much time do you spend doing this on a usual day? 
  1 Hours:   
            2 Minutes:    
8.1M 
In your leisure or spare time, do you do any moderate-intensity activities that 
cause a small increase in breathing or heart rate (like brisk walking, volleyball, 
cycling or 





 If no, go to question 8.1P 
8.1N 
In a usual week, how many days do you do moderate-intensity activities as 
part of your leisure  
 
Or spare time?           
Days: 
  
8.1O How much time do you spend doing this on a usual day? 
  Hours:   
  Minutes:    
 
Sitting / resting activity:  now I would like to ask you about the time spent 
sitting or resting, not including sleeping, in the past 7 days.  This may include 
time sitting at a desk, visiting friends, reading, or sitting down to watch 
television during working hours and leisure or spare time. 
8.1P 
Over the past 7 days, how much time did you spend sitting or reclining (lying) 
on a usual day (excluding sleeping)? 
  Hours:   









SECTION 8.2   EATING HABITS      
How often and what quantities do you usually eat the following products? 





times a day  
how many 
days a 
week    
8.2B Pap Serving spoon    
8.2C Rice/ pasta Serving spoon    
8.2D Potatoes Numbers     
8.2E Meat Matchbox size 
beef/ chicken 
piece 
   
8.2F Take away eg 
KFC, pizza 
Frequency     





   
8.2I Vegetables 1/2cup    
8.2J Added sugar teaspoon    
How much and how often do you normally drink the following? (Tick in one column 
1-5) 
  Quantity 
 
How many 







    
8.2K Soft 
drinks/fizzy 




can/ king size  
   
8.2L water 250ml cup    
8.2M Juice with 
added sugars 
eg oros,fruitree 
500mls    
8.2N Alcohol 
beverages 
330mls glass    










8.3 Screening for T2DM 




 Have you ever participated in any 
screening program for diabetes? 
Yes….1 No ….0 
8.3B If you were ever screened for diabetes, 
what was the result of the test? 
Diabetes 
 
Pre diabetes – 
slightly elevated 
blood sugar levels 
which may 





































Alterations after pilot study was done 
In section 3 under family medical history, question 4B was disregarded after piloting 
as it was seen that most participants did not know about the history of gestational 
diabetes for their female 1st-degree relatives. Question 5B initially had an option of 
selecting one source of information, but we noticed participants opted to choose 
various sources of information so an instruction to select all applicable sources was 
added. The question which asks if  “consuming more sugar-sweetened beverages 
such as coca-cola and sweetened foods may make one more easily develop T2DM or 
not” was adjusted and directly translated from siSwati so that participants understood 
what was meant by excessive sugar consumption. The question, “Can diabetes 
mellitus be treated?” tended to be confused with the management of diabetes, 
therefore, during the main interview, it was clarified that treatment referred to the actual 
















VIGOROUS Intensity Activities 
















• Forestry (cutting, chopping, carrying wood) 
• Sawing hardwood 
• Ploughing 
• Cutting crops (sugar cane) 
• Gardening (digging) 
• Grinding (with pestle)  
• Labouring (shovelling sand) 
• Loading furniture (stoves, fridge) 
• Instructing spinning (fitness) 
• Instructing sports aerobics 
• Sorting postal parcels (fast pace) 
• Cycle rickshaw driving 
 
 
Moderate Physical Activity at Work 
MODERATE Intensity Activities 






































• Cleaning (vacuuming, mopping, polishing, scrubbing, sweeping, ironing) 
• Washing  (beating and brushing carpets, wringing clothes (by hand) 
• Gardening 
• Milking cows (by hand) 
• Planting and harvesting crops 
• Digging dry soil (with spade) 
• Weaving  
• Woodwork (chiselling, sawing softwood) 
• Mixing cement (with shovel) 
• Labouring (pushing loaded wheelbarrow, operating jackhammer) 
• Walking with load on head 
• Drawing water 














VIGOROUS Intensity Activities 














• Soccer  
• Rugby 
• Tennis 
• High-impact aerobics  
• Aqua aerobics  
• Ballet dancing 












































MODERATE Intensity Activities 






• Jogging  
• Dancing  
• Horse-riding  
• Tai chi 
• Yoga 
• Pilates 
• Low-impact aerobics 
• Cricket 
*Activities VI. Physical Activity Vigorous Physical Activity at Work Moderate Physical 
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subheading. Tables and figures central to the study should be included in the main 
paper. The Results section should be written in past tense. 
PLOS journals require authors to make all data underlying the findings described in 
their manuscript fully available without restriction, with rare exception. 
Large data sets, including raw data, may be deposited in an appropriate public 
repository. See our list of recommended repositories. 
For smaller data sets and certain data types, authors may provide their data 
within Supporting Information files accompanying the manuscript. Authors should 
take care to maximize the accessibility and reusability of the data by selecting a file 
format from which data can be efficiently extracted (for example, spreadsheets or flat 
files should be provided rather than PDFs when providing tabulated data). 
For more information on how best to provide data, read our policy on data 
availability. PLOS does not accept references to “data not shown.” 
As outlined in the Uniform Requirements:  
 
Give numeric results not only as derivatives (for example, percentages) but also as 
the absolute numbers from which the derivatives were calculated, and specify the 
statistical significance attached to them, if any. Restrict tables and figures to those 
needed to explain the argument of the paper and to assess supporting data. Use 
graphs as an alternative to tables with many entries; do not duplicate data in graphs 




” (which implies a randomizing device), “normal,” “significant,” “correlations,” and “
sample.” 
Discussion 
The Discussion should be concise and tightly argued. It should start with a brief 
summary of the main findings. It should include paragraphs on the generalizability, 
clinical relevance, strengths, and limitations of your study. 
You may wish to discuss the following points also: 
How do the conclusions affect the existing knowledge in the field? 
How can future research build on these observations and what are the key 
experiments that must be done? 
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